Circulation 136:849870 Honigberg MC, Chang LS, McGuire DK, Plutzky J, Aroda VR, Vaduganathan M (2020) Use of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and Cardiovascular Disease: A Review
Among women aged 45-54, prescribing increased more than 180%, with nearly 1 in 20 patients receiving therapy by early 2026
That being said, not everyone with this condition notices anything unusual
Our GH treatments may improve your muscle mass and decrease body fat percentage
In this narrative literature review, we explore the pharmacological properties of tirzepatide and critically summarize and comment on the results of the clinical studies conducted thus far, as well as discuss the potential implications for the treatment of obesity, T2DM, and associated cardiometabolic complications